Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial is a study to test a device called the Edwards PASCAL Transcatheter Valve Repair System. It helps fix the heart's mitral valve in patients with two types of mitral regurgitation (MR), where blood leaks backward in the heart. People with degenerative mitral regurgitation (DMR) can't have regular surgery, and those with functional mitral regurgitation (FMR) are on special heart medicines. The study compares this device to another device called MitraClip.
Participants will have follow-up visits after the procedure at 30 days, 6 months, and then every year for 5 years.
- This study requires long-term follow-up visits for up to 5 years.
- Participants must be 18 or older and willing to follow study guidelines.
- Certain heart conditions or recent surgeries can exclude you from participation.
If you're interested, you should talk to your doctor to see if you qualify and understand any risks involved. They will help decide if this study is a good choice for you.